PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryAug 6, 2002	Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents PLAINSBORO, N.J., Aug. 6, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) and REVA Medical, Inc.	View HTML Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents 13.9 KB
Toggle SummaryAug 1, 2002	Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the	View HTML Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business 14.8 KB
Toggle SummaryAug 1, 2002	Integra LifeSciences Reports Second Quarter Earnings Per Share of $0.14 on Record Revenues of $26.4 Million Integra LifeSciences Reports Second Quarter Earnings Per Share of $0.14 on Record Revenues of $26.4 Million PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues of $26.4 million and net income of $0.14 per share for the	View HTML Integra LifeSciences Reports Second Quarter Earnings Per Share of $0.14 on Record Revenues of $26.4 Million 14.8 KB
Toggle SummaryAug 1, 2002	Integra LifeSciences Announces Acquisition of Signature Technologies, a Specialty Manufacturer of Neurosurgical and Spinal Implants Integra LifeSciences Announces Acquisition of Signature Technologies, a Specialty Manufacturer of Neurosurgical and Spinal Implants PLAINSBORO, N.J. and Pembroke, Mass., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the	View HTML Integra LifeSciences Announces Acquisition of Signature Technologies, a Specialty Manufacturer of Neurosurgical and Spinal Implants 14.8 KB
Toggle SummaryJul 29, 2002	Integra LifeSciences Schedules Conference Call for Tuesday, August 6 to Discuss Second Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance; Announces Participation in Adams, Harkness & Hill Annual Summer Seminar Integra LifeSciences Schedules Conference Call for Tuesday, August 6 to Discuss Second Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance; Announces Participation in Adams, Harkness & Hill Annual Summer Seminar PLAINSBORO, N.J.-July 29, 2002-- Integra LifeSciences Holdings	View HTML Integra LifeSciences Schedules Conference Call for Tuesday, August 6 to Discuss Second Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance; Announces Participation in Adams, Harkness & Hill Annual Summer Seminar 10.5 KB
Toggle SummaryJul 15, 2002	Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge Plainsboro, New Jersey, July 15, 2002-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Absorbable Collagen Sponge	View HTML Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge 12.4 KB
Toggle SummaryMay 8, 2002	Integra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million Integra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million PLAINSBORO, N.J., May 8, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported record revenues of $25.9 million and net income of $0.13 per share for the	View HTML Integra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million 18.2 KB
Toggle SummaryApr 23, 2002	Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures PLAINSBORO, N.J., April 23, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that the U.S.	View HTML Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures 13.1 KB
Toggle SummaryApr 9, 2002	Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter PLAINSBORO, N.J., April 9, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that	View HTML Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter 10.5 KB
Toggle SummaryApr 5, 2002	Integra LifeSciences Reports Preliminary First Quarter 2002 Revenues; Forward-Looking Earnings Guidance Unchanged Integra LifeSciences Reports Preliminary First Quarter 2002 Revenues; Forward-Looking Earnings Guidance Unchanged PLAINSBORO, N.J., April 5, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported preliminary revenues for the first quarter ended March 31, 2002.	View HTML Integra LifeSciences Reports Preliminary First Quarter 2002 Revenues; Forward-Looking Earnings Guidance Unchanged 13.3 KB